人类抑郁症中差异表达的microRNAs:对病例控制和纵向研究的系统审查
Yangyang He1,2, Sanne Houtenbos3,4, Pia-Maria Wippert3,4
1Medical Sociology and Psychobiology, University of Potsdam, Am Neuen Palais 10, 14469, Potsdam, Germany. yangyang.he@uni-potsdam.de.
BMC psychiatry
|July 2, 2025
概括
微RNAs (miRNAs) 在抑郁症中表现出改变,表明它们作为诊断和治疗标记物的潜力. 本综述综合了关于miRNA参与抑郁症的证据.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 精神病学是一个精神病学.
背景情况:
- 抑郁症是一种复杂的精神疾病,影响认知,情绪和行为.
- 微RNAs (miRNAs) 是小的,非编码RNAs影响与抑郁相关的生物过程.
- 了解miRNA的作用对于开发新的抑郁症诊断和治疗方法至关重要.
研究的目的:
- 系统地审查和综合有关抑郁症患者改变miRNA表达的现有证据.
- 为未来的临床应用阐明抑郁症和miRNAs之间的复杂相互作用.
主要方法:
- 在PubMed和Web of Science数据库中进行了系统的文献搜索.
- 包括研究涉及人类抑郁症,调查miRNA变化,并是病例对照或纵向研究.
- 通过NIH质量评估工具评估研究质量,然后对研究结果进行综合.
主要成果:
- 包括37项涉及2909名患者的研究,揭示了抑郁症中48个不同的miRNA变化.
- 七个miRNAs (miR-146a-5p,miR-132-3p,miR-124-3p,miR-16-5p,miR-155-5p,miR-135a-5p,miR-451a) 显示了一致的变化. 在这些变化中,miR-146a-5p,miR-132-3p,miR-124-3p,miR-16-5p,miR-155-5p,miR-135a-5p,miR-451a) 显示了一致的变化.
- 这些miRNAs主要参与调节神经生物学过程.
结论:
- 各种miRNA与抑郁症的病理生理学有关.
- 改变的miRNAs代表了抑郁症的潜在诊断和治疗生物标志物.
- 这些发现有助于对基于miRNA的生物标志物和抑郁症治疗方法的理解.
相关概念视频
Depression: Overview
361
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
361
Depressive Disorders: MDD and Dysthymia
225
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
225
Depressive Disorders: Etiology
173
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
173
MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Long-term Depression
31.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.5K
Antidepressant Drugs: MAOIs and Other Agents
377
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
377


